Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia.

Fisihatsion TadesseGetahun AsresAbdulaziz AbubekerAmha GebremedhinJerald Radich

Published in: JCO global oncology (2021)

In Ethiopia, CML affects the young and point mutations were frequently detected in imatinib-resistant patients. BCR-ABL1 35INS was also prevalent and associated with disease progression.

Keyphrases

chronic myeloid leukemia
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
acute lymphoblastic leukemia
patient reported